TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | 2 | 0 | 4 | -2 | -1 | 1 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/25/21 20:03 | 5/25/21 | ADTX | Aditx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pankovcin Corinne | CA | O | CFO | P | 11 | 2.56 | 0 | 4 | 4 | 114 | D | ||||||||||||||
8/5/15 12:40 | 8/3/15 | BKCC | Blackrock Capital Investment Corp | Fund | CEF | Closed-End Funds | Pankovcin Corinne | NY | O | CFO | P | 30 | 9.25 | 3 | 3 | New | 3 | M | 10 | 15 | 18 | 3 | -1 | 0 | 6 | -1 | 2 | 2 | 0 | 4 | -2 | -1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |